Medical Device Playbook is Canada’s largest Medtech event for entrepreneurial companies and medical device professionals. Medical Device Playbook Toronto 2022 returns to the MaRS Discovery District on October 6, 2022.
Medical device commercialization information and inspiration for medtech entrepreneurs, start-ups, and entrepreneurial organizations.
Industry speakers and panels from across North America will discuss, network and learn 2022 trends, opportunities, and Efficient Medtech Start-Up strategies. Presentations include entrepreneur case studies, success stories, deal making, financing and clinical/regulatory advice from industry veterans.
Event includes Lunch, Breaks, and Networking Reception. Medical Device Playbook Toronto 2022 is presented by StarFish Medical and co-hosted with MaRS, and OBIO.
Dr. Lishan Aklog is Chairman & CEO of PAVmed (Nasdaq: PAVM), a diversified medical technology company which he co-founded, and its subsidiary Lucid Diagnostics, a cancer prevention company (Nasdaq: LUCD) as well as Executive Chairman of it other subsidiary Veris Health, a cancer care digital health company. He also serves on the board of the leading medtech industry group, AdvaMed, and as an independent public company director. He previously co-founded a medtech holding company which founded four medical device companies and led one of its portfolio companies, which commercialized one of his life-saving inventions, AngioVac®. Dr. Aklog has consulted for leading medtech companies and is an inventor on dozens of patents. Healthcare Technology Report recognized him as a Top Healthcare Technology CEO of 2021 and 2022. Prior to entering the life sciences industry as an entrepreneur and executive, Dr. Aklog had a distinguished career as an innovator in cardiac surgery, serving on the faculty of leading academic medical centers including Harvard Medical School, in professional society leadership positions. and was recognized as an America’s Top Doctor for over a decade. He received his undergraduate degree in Physics, magna cum laude, and MD, cum laude, from Harvard University. He completed his training at Harvard teaching hospitals and leading medical centers in London and Paris. Dr. Aklog, who fled political violence in Ethiopia as a young teenager, has been active in philanthropic organizations, including as a member of the international board of directors of Human Rights Watch.
Ali Ardakani is a technical and entrepreneurial corporate development and operations biotech executive with over 20 years of experience in managing life science projects and companies. His experience includes managing R&D projects in the areas of oncology, respiratory, infectious disease, CNS therapeutics and medical devices, as well as fundraising, licensing and M&A.
Ali is the Founder & Managing Director of Novateur Ventures. Until recently he was Senior Vice President Device & Business Development for Beyond Air (NASDAQ:XAIR), where he was involved with the company from early stage until Nasdaq public offering and several rounds of financing and licensing. He is the CEO and co-founder of Optigo Biotherapeutics, an ophthalmology R&D company, the Vice Chair of LifeSciences BC, and Entrepreneur in Residence at Innovate Calgary. He is also an Associate at Creative Destruction Labs.
To date, Ali has taken several projects from concept to FDA approval, including several 510(k)s, PMA for medical devices and several FDA INDs. He has also worked on commercialization and pharma partnerships, as well as several global mergers and acquisitions.
I’m Chris, the Founder and CEO of Cyberdontics. Cyberdontics is empowering dentists with automated robotics. We are starting with the dental crown - the most frequent and effortful dental procedure.
Currently in stealth-mode, Cyberdontics is a rapidly scaling, venture-backed startup at the vanguard of automated robotic surgery revolution -- just closed our Series A round. We are improving access to dental care in underserved populations by combining novel imaging technology with AI and surgical robotics to automate surgery in the $452B dental industry.
We are bringing a new imaging modality to dentistry which can see inside teeth and below the gingiva all without the need for x-rays. AI is used to diagnose decay and plan treatment. Automated robotics reduces the time for surgery down to one minute, reducing patient discomfort and saving time and reducing cost for the dentist.
Chris is YC 2020, Winner of the Forsyth DenTech 2021 CareCaptial award.
Prior to launching Cyberdontics, he built a 60-person Dental Service Organization (DSO) which employs top-performing dentists, is growing, and is run by professional practice managers.
Chairman and Chief Science Officer at Strōma Medical Corporation.
Gregg Homer grew up in Los Angeles, California. He began inventing at age 12, when he put espresso grind coffee in a tea bag for instant steeped coffee and sold the invention to Hills Bros. Coffee in San Francisco for $2,000.
While in high school, Dr. Homer worked as a studio musician (piano and guitar) for Epic Records, as a close-up magician at the Magic Castle, and as an understudy in the LA cast of “Hair.” At 16, two years before graduation, Dr. Homer dropped out of high school to attend Immaculate Heart College in Los Angeles. He graduated with a BA in English and spent his final year in the graduate creative writing program. Dr. Homer then attended Stanford Law School, where he graduated at the top of his class and served as a senior editor of the Stanford Law Review.
Dr. Homer practiced entertainment law in Los Angeles for two decades, served as an arbitrator for the Screen Actor’s Guild, and taught the entertainment law curriculum at Stanford Law School for several years. While at Stanford, Dr. Homer completed an interdisciplinary doctorate in evolutionary neurology and economic game theory, writing his dissertation on the co-evolution of the neural system and social order.
Dr. Homer’s time at Stanford also reignited his early passion for invention and innovation. His first patent claimed a method for monitoring internet packets, now known as “deep packet inspection.” His next patent claimed the on-demand distribution of media files over the internet on a subscription basis, now know as “subscription on demand” and reflected in such delivery platforms as Netflix, Spotify, Hulu, Apple Music, and Amazon Prime. Dr. Homer’s third invention was laser eye color change, which has been developed for commercialization by Strōma Medical Corporation. Dr. Homer continues to invent, primarily in the fields of medical devices, media and communications, and enterprise software applications.
Imants Lauks is currently Executive Chairman of Questat Inc. Ottawa Canada. He obtained a B.Sc. in Chemistry and a Ph.D. in Electrical Engineering both from Imperial College, London England. He came to the United States in 1977 as a post doc at the University of Pennsylvania, where he later joined the faculty of the Moore School of Electrical Engineering gaining tenure in 1983. His work at Penn involved the development of silicon-based biosensors. In 1984 Dr Lauks founded i-STAT Corporation. As Chief Technology Officer he led a team that commercialized his silicon-based biochip technology and developed hand-held blood analyzers for use at the point of care. The i-STAT system was launched in 1989, and the Company was ultimately acquired by Abbott Laboratories. In 2001 Dr Lauks founded Epocal Inc. as Chief Executive Officer he led the commercialization of a new generation of point of care blood analysers based on smart-card technology. The EPOC analyzer was launched in 2007, and the Company was ultimately acquired by Alere, with ownership transferred to Siemens in 2017. In 2021 Dr Lauks founded Questat to commercialize a third-generation acute care point of care technology.
Scott Phillips is CEO and Founder of StarFish Medical. Scott holds a degree in Engineering Physics from the University of British Columbia. Prior to starting StarFish, he worked in diverse areas such as lithium battery development and manufacturing, UV spectroscopy instrumentation and hi-fi audio speakers. Under his leadership StarFish has grown into a diverse professional organization with clients around the world and 100% focus on medical devices. Scott is a Fellow of The Canadian Academy of Engineering, winner of the EY Entrepreneur Of The Year™ 2017 Pacific Awards Technology category, 2017 recipient of the VIATEC Technology Champion award, member of the LifeSciences British Columbia board, and volunteers with Junior Achievement, Entrepreneurs Organization, and University of British Columbia.
Partner and Account Executive at MegaLab Group Inc.
David Bell is a partner and Account Executive at MegaLab Group Inc. To get medical electrical equipment to market, manufacturers must get through the IEC 60601 series of tests. With a 40,000 square foot test lab in Aurora Ont that includes a 10 meter EMC chamber, product safety, environmental, shock / vibration and packaging testing, MegaLab Group is a local one stop for certification and testing of medical devices and can guide clients through the maze of requirements.